BioCentury

8:00 AM GMT, Jan 3, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

VEGF Trap-Eye: Additional Phase II data

Additional data from the double-blind, international Phase II DA VINCI trial in 219 patients showed that all 4 doses of intravitreal VEGF Trap-Eye maintained significant improvements from

Read the full 275 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.